News

TRN excited to announce our new Cardiovascular and Metabolic Disease Team 

The Research Network (TRN) is excited to announce that a new Therapeutic Team has joined the network - the Cardiovascular and Metabolic Disease Team.

The Cardiovascular and Metabolic Disease group evolved from scientists of the AstraZeneca Alderley Park, UK and Pfizer US sites.  Through us you have immediate access to over 200 years of successful metabolic disease drug discovery and development expertise in the fields of medicinal chemistry, biochemistry, molecular biology, in vitro and in vivo pharmacology, physiology, small molecule, peptide and protein science.    

TRN's Simon Poucher's publication on treatment of type 2 diabetes 

Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus.

TRN team raise £438.50 for Cancer Research UK. 

The TRN team embraced the festive spirit yesterday and raised £438.50 at the Discovery Park Christmas Fair. There were nearly thirty stalls selling anything from cheese to knitted dolls. The TRN stall which sold small Christmas gifts, cakes, jams and toys was a great success. The raffle also drew in the crowds and the team were incredibly proud to have raised so much money for such a worthy cause.